Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target

Citations Over TimeTop 1% of 2020 papers

Abstract

Sirtuin 3 (SIRT3) is one of the most prominent deacetylases that can regulate acetylation levels in mitochondria, which are essential for eukaryotic life and inextricably linked to the metabolism of multiple organs. Hitherto, SIRT3 has been substantiated to be involved in almost all aspects of mitochondrial metabolism and homeostasis, protecting mitochondria from a variety of damage. Accumulating evidence has recently documented that SIRT3 is associated with many types of human diseases, including age-related diseases, cancer, heart disease and metabolic diseases, indicating that SIRT3 can be a potential therapeutic target. Here we focus on summarizing the intricate mechanisms of SIRT3 in human diseases, and recent notable advances in the field of small-molecule activators or inhibitors targeting SIRT3 as well as their potential therapeutic applications for future drug discovery.

Related Papers

• → Regulation of SIRT1 and Its Roles in Inflammation(2022)613 cited
• → Expression of sirtuins in ovarian follicles of postnatal mice(2020)9 cited
• → Neuroprotective mechanisms of SIRT1(2009)
• → Effect of caloric restriction on the expression of the Sirtuin Proteins(2012)
• → P6-003 Sirtuin-1はヒト単球のinterleukin-10制御に関与する(2014)